Aerobic Exercise
BehavioralPatients with mild cognitive impairment will undergo a one-year aerobic exercise program of 3 units of 45 min / week
NCT Number: NCT02913053
Exercise interventions to prevent dementia and delay cognitive decline have gained considerable attention in recent years. Human and animal studies have demonstrated that regular physical activity targets brain function by increasing cognitive reserve. Although initial studies indicate enhanced cognitive performance in patients with mild cognitive impairment (MCI) following an exercise intervention, little is known about the effect of an extensive, controlled and regular exercise regimen on the neuropathology of patients with MCI.
The aim of this study is to compare a 12- month aerobic exercise programme versus a stretching and toning (non-aerobic) programme versus a control group on the progression of cognitive decline in MCI.
It is hypothesized that MCI-related decreases in cognitive and psychomotor functioning will show less progression or even be improved after a one-year aerobic exercise intervention compared to a group of patients undergoing stretching and toning exercise as well as to a control group provided with no intervention.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
German Sport University, Cologne, Germany
This randomised controlled clinical intervention study will take place across three European sites; the German Sport University Cologne, Germany, University of Nijmegen, The Netherlands and Trinity College Dublin, Ireland. Seventy-five previously sedentary patients with a clinical diagnosis of MCI will be recruited at each site. Participants will be randomised to one of three intervention arms. One group will receive a standardised one-year extensive aerobic exercise intervention (3 units of 45min / week). The second group will complete stretching and toning (non-aerobic) exercise (3 units of 45min / week) and the third group will receive usual care. Change in all outcomes will be measured at baseline (T0), after six months (T1) and after 12 months (T2).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients with mild cognitive impairment will undergo a one-year aerobic exercise program of 3 units of 45 min / week
Patients with mild cognitive impairment will undergo a one-year stretching and toning (non-aerobic) exercise program of 3 units of 45 min / week
Time frame: One year
Cognitive performance will be assessed by an extensive neuropsychological test battery
Time frame: One year
MoCA (Montreal Cognitive Assessment)
Time frame: One year
(sub)maximal ergometer exercise test
Time frame: One year
Activity monitoring with accelerometers
Time frame: One year
Health Related Quality of Life for People with Dementia (DemQOL)
Time frame: One year
Center for Epidemiologic Studies Depression (CES-D)
Time frame: One year
Personality traits assessment
Time frame: One year
Frailty measurement
Time frame: One year
Frailty measurement
Time frame: One year
Frailty measurement
Time frame: One year
Genotyping of the Apolipoprotein E (APOE) 4 allele in venous blood.
Time frame: 6 months
Magnetic Resonance Imaging (MRI) scan: brain structure
Radboud University Medical Center
Other
The Effects of an Extensive Exercise Program on the Progression of Mild Cognitive Impairment (MCI)
Acronym: NeuroExercise
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT04070703
Cognition Disorders, Cognitive Dysfunction
Eugene, Oregon, United States
View Trial DetailsNCT07554144
Adolescent Development, Attention Impaired
Kütahya, Centre, Turkey (Türkiye)
View Trial DetailsNCT07729865
Cognition Disorders, Cognitive Dysfunction
Lahore, Punjab Province, Pakistan
View Trial Details